InvestorsHub Logo

pete807

03/08/21 4:16 PM

#6807 RE: dndodd #6806

Skin grafting in any form is not competition for RCEL.

The risk of infection alone is many fold higher with grafting. There is nothing competing apples for apples with this less invasive technology using your own compatible cells and healing without scarring over the entire wound surface at once instead of from the edges inward. Grafting is cutting and pasting living tissue, requiring anti-bacterial protocols, drugs and dressings.

Thousands have already benefitted from RCEL but it is early in the process of complete acceptance as the paradigm for burns and regenerating skin surely to come with nothing like it or likely to compete.

I am in my third year as a long. While I believe in RCEL, I bought and sold to reach a free position. There is more development and juvenile use approval is needed before a company buyout comes. The technology is not for sale, nor will it go to the distributor/buyer of the company. The foundation created by Dr Wood owns the patents.

I am not a doctor. Please do your own research.

Good Luck!

-pete

MONYMAN3

03/08/21 8:56 PM

#6808 RE: dndodd #6806

I looked into StrataGraft quite a while back with similar concerns about competition. From what I recall a graft is taken sent off to be processed then weeks later applied to the wound surface. Not ideal imo. Rcel is applied virtually in real time of the injury (30 minutes). Not really a threat.